Peer Review History

Original SubmissionAugust 19, 2024
Decision Letter - Masaki Mogi, Editor

PONE-D-24-34309A scoping review protocol on brain PCO2 levels at altitudePLOS ONE

Dear Dr. Tang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 19 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Masaki Mogi

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The manuscript has been evaluated by two reviewers. See the suggestions carefully and respond them appropriately.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Tang and colleagues described a scoping review protocol that maps the current literature to determine if blood arterial pressure of CO2 (PaCO2) acutely changes at high altitudes during aeromedical transportation. The authors provide details of how the study will be conducted, including inclusion and exclusion criteria, search strategy, evidence selection, data extraction and analysis. Overall, this protocol could be novel to understanding the PaCO2 changes in patients with ischemic stroke during aeromedical transportation.

Points of concern are outlined below:

1.Helicopter cabins are usually not pressurized. Since cabin pressure is not considered an inclusion criteria factor, the authors should include a short discussion on how cabin pressure may affect the PaCO2.

2.The authors mention in lines 173-175 that the current protocol may have a potential limitation in that the number of related studies may be small. Do the authors have an estimated number of literatures before and after the screening?

3.Please provide a discussion session that expands on the current “Strengths and Limitations” and briefly elaborates on factors like high altitude exposure format (helicopter, airliners, mountain climbing, chamber), exposure time, etc, that could complicate data interpretation.

4.Keep the PaCO2 acronym consistent.

Reviewer #2: Title: A scoping review protocol on brain PCO2 levels at altitude

Here is the review of the manuscript by Hanna Tang et al., which is a scoping review protocol on brain PCO₂ levels at altitude in critically ill patients. The authors address an interesting and clinically relevant question about the potential effects of rapid changes in altitude and atmospheric pressure on cerebral perfusion and ischemic burden during aeromedical transport of patients with ischemic stroke. This is a well-written and engaging scoping review protocol that clearly outlines the objectives, methods, and reporting approach for the review.

That said, I have a few minor suggestions for improvement:

Exclusion Criteria: The authors indicate that they will exclude studies involving participants under 18 years of age. However, it is unclear why this exclusion criterion is necessary for their review.

Measurement of PaCO₂: The authors specifically aim to include studies that report arterial partial pressure of CO₂ (PaCO₂) at two different altitudes. Since studies may measure PaCO₂ either directly (e.g., via arterial blood gas) or indirectly, the authors should clarify their criteria regarding acceptable methods for PaCO₂ measurement.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers:

Reviewer 1:

Comment 1: Helicopter cabins are usually not pressurized. Since cabin pressure is not considered an inclusion criteria factor, the authors should include a short discussion on how cabin pressure may affect the PaCO2.

Response: This is an excellent point. Although rotary wing transfers are the most commonly used airframe for aeromedical transfers and are often unpressurized, fixed wing transport at higher altitudes is required for longer distances; fixed wing cabins for medical transfer are invariably pressurized, often to an equivalent altitude 2,000-8,000 feet. We have included the following in our concepts section under inclusion criteria: “Higher cabin pressure is favoured from a medical perspective for the patient since it creates a relatively less hypoxic hypobaric environment.” The trade-off is that a pressurized cabin will increase fuel usage and on some flight distances, result in longer flight times due to the need for refueling. We have not included cabin pressure as an inclusion criteria since we would like to first scope all available literature in the field to see if altitude affects PaCO2, and since cabins are normally pressurized to over 1000 feet. If there is a pressurized cabin system, we will note in our review the equivalent altitude to which the cabin was pressurized.

Comment 2: The authors mention in lines 173-175 that the current protocol may have a potential limitation in that the number of related studies may be small. Do the authors have an estimated number of literatures before and after the screening?

Response: Based on the initial search, we have found 491 articles prior to screening. We are not yet able to estimate the number of studies after screening, as we are awaiting approval of the final protocol before screening to maintain methodological rigor.

Comment 3: Please provide a discussion session that expands on the current “Strengths and Limitations” and briefly elaborates on factors like high altitude exposure format (helicopter, airliners, mountain climbing, chamber), exposure time, etc, that could complicate data interpretation.

Response: We have elaborated on the “Strengths and Limitations” section. The following was added to the protocol: “It is unclear if altitude of aeromedical transportation would affect the rate of ischemic burden. If there is evidence that suggests that PaCO2 is impacted at cruising altitudes of aeromedical transport, then it opens the door to further studies in this area… Our preliminary search result yielded articles with various formats of high altitude exposure such as air transport, mountain climbing, and residing at high altitudes. One way we aim to address this weakness and make it more applicable to our clinical context is to ensure that PaCO2 was measured in at least two altitudes. Depending on the final list of included articles, it is not known if there will be sufficient evidence to comment on how brief exposures to high altitude impacts PaCO2. However, this could also in turn open the door to future studies to fill the potential knowledge gap.”

Comment 4: Keep the PaCO2 acronym consistent.

Response: Thank you for bringing this to our attention. This has been corrected.

Reviewer 2:

Comment 1: Exclusion Criteria: The authors indicate that they will exclude studies involving participants under 18 years of age. However, it is unclear why this exclusion criterion is necessary for their review.

Response: The majority of the Canadian Stroke Guidelines are for patients aged 18 and older. Ultimately the goal of this study is to provide future direction to improve our adult stroke care, which is the population who we serve clinically. Additionally, it is unclear if neonates and/or children would have the same hypoxic drive to breathe at altitude as in adults. But we appreciate the comment and agree after this initial review, our team will consider a similar assessment in the pediatric population.

Comment 2: Measurement of PaCO₂: The authors specifically aim to include studies that report arterial partial pressure of CO₂ (PaCO₂) at two different altitudes. Since studies may measure PaCO₂ either directly (e.g., via arterial blood gas) or indirectly, the authors should clarify their criteria regarding acceptable methods for PaCO₂ measurement.

Response: Very good point – we have now included the following statement in our inclusion criteria: “We will include studies that comment on PaCO2 measured both directly via arterial blood gas and indirectly.”

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Masaki Mogi, Editor

A scoping review protocol on brain PaCO2 levels at altitude

PONE-D-24-34309R1

Dear Dr. Tang,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Masaki Mogi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Tang and colleagues described a scoping review protocol that maps the current literature to determine if blood arterial pressure of CO2 (PaCO2) acutely changes at high altitudes during aeromedical transportation. The authors provide details of how the study will be conducted, including inclusion and exclusion criteria, search strategy, evidence selection, data extraction and analysis. Overall, this protocol could be novel to understanding the PaCO2 changes in patients with ischemic stroke during aeromedical transportation. The authors have addressed all my concerns. I don't have any further comments.

Reviewer #2: Here is the review of the manuscript by Hanna Tang et al., which is a scoping review protocol on brain PCO₂ levels at altitude in critically ill patients. The authors address an interesting and clinically relevant question about the potential effects of rapid changes in altitude and atmospheric pressure on cerebral perfusion and ischemic burden during aeromedical transport of patients with ischemic stroke. This is a well-written and engaging scoping review protocol that clearly outlines the objectives, methods, and reporting approach for the review. The concerns I had now well addressed and I suggest accepting the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Masaki Mogi, Editor

PONE-D-24-34309R1

PLOS ONE

Dear Dr. Tang,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Masaki Mogi

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .